# SCRIPT REVISIONS - SUMMARY & NEXT STEPS
# Voice Acoustics & Personality Pathology Study
# ==============================================================================

## WHAT HAS BEEN CORRECTED

### 1. Sample Composition âœ“
**Problem**: Sample was female-only but not disclosed
**Solution**: 
- Script 01: Added explicit comments about female-only sample
- README: Clear documentation of sample composition
- Notes for manuscript: Must state in abstract and methods

### 2. Variable Naming Consistency âœ“
**Problem**: Mismatch between Script 03 (`pid5_*_c`) and Script 04 (`pid5_*_bl_c`)
**Solution**:
- All scripts now use consistent naming: `pid5_negative_affectivity_c`, etc.
- Script 03 copied as-is (already correct)
- Script 04 will need updating (see below)

### 3. Missing Analyses âœ“
**Problem**: Abstract claims not supported by analyses
**Solutions Added**:

#### a) EMA Validation (Script 02)
- **What**: Correlations between EMA (15 items) and PID-5 full (220 items)
- **Why**: Demonstrates brief EMA captures trait variance
- **Output**: Convergent validity plot + correlation table

#### b) Temporal Covariation (Script 08) â­ NEW
- **What**: Within-person coupling between EMA fluctuations and voice
- **Why**: Supports claim "co-varied temporally with acoustic changes"
- **Method**: Decomposes between-person vs within-person variance
- **Output**: Within-person effect estimates for each trait

#### c) Model Comparison (Script 09) â­ NEW
- **What**: Compare predictive accuracy of EMA vs baseline PID-5
- **Why**: Supports claim "EMA added predictive value beyond baseline"
- **Method**: RÂ² and LOO-IC comparison
- **Output**: Model comparison table with differences

### 4. Documentation âœ“
- Created comprehensive README with execution order
- Added troubleshooting section
- Documented expected results and runtimes

---

## REVISED SCRIPT FILES

### Core Analysis
1. `01_clean_after_merge_FINAL.R` - âœ“ Updated with sample disclosure
2. `02_voice_personality_analysis_FINAL.R` - âœ“ Added EMA validation
3. `03_moderation_analysis_FINAL.R` - âœ“ Copied (already correct)

### New Supplementary Analyses
4. `08_temporal_covariation_analysis.R` - â­ NEW (within-person coupling)
5. `09_model_comparison_EMA_vs_Baseline.R` - â­ NEW (EMA vs baseline)

### Existing Supplementary
6. `07_disinhibition_alternative_models.R` - Keep as-is (provides useful findings)

### Documentation
7. `README_ANALYSIS_PIPELINE.md` - âœ“ Complete execution guide

---

## WHAT YOU NEED TO DO NOW

### IMMEDIATE (Before Running Scripts)

1. **Verify data files exist**:
   ```
   data/processed/ema_plus_scales_merged.RDS
   data/raw/meta/all_combined_sex_NEW_1.xlsx
   data/raw/acustic_features/datiacustici/AUDIO.xlsx
   ```

2. **Check baseline PID-5 variables**:
   - Open `ema_plus_scales_merged.RDS`
   - Verify it contains: `domain_negative_affect_baseline`, etc.
   - These are needed for Script 09 (model comparison)

3. **Run scripts in order**:
   ```r
   # Core analysis (required)
   source("01_clean_after_merge_FINAL.R")
   source("02_voice_personality_analysis_FINAL.R")
   source("03_moderation_analysis_FINAL.R")
   
   # Supplementary (strongly recommended)
   source("08_temporal_covariation_analysis.R")
   source("09_model_comparison_EMA_vs_Baseline.R")
   source("07_disinhibition_alternative_models.R")  # if time allows
   ```

### AFTER RUNNING SCRIPTS

4. **Check key results** (see README section "KEY RESULTS TO VERIFY")

5. **Verify replication** of abstract claims with N = 141:
   - NA Ã— Stress â†’ F0: Î² â‰ˆ 5 Hz [1.26, 8.76]
   - Detachment Ã— Recovery: Î² â‰ˆ -4.37 [-8.30, -0.46]
   - Antagonism Ã— Recovery: Î² â‰ˆ 3.44-4.17
   - Disinhibition Ã— F2: Î² â‰ˆ 63 Hz [26, 99]

6. **Review new findings**:
   - EMA validation: Are correlations > 0.50? (ideally > 0.70)
   - Temporal covariation: Any significant within-person effects?
   - Model comparison: Does EMA add value over baseline?
   - Disinhibition main effect: Robust?

---

## EXPECTED RESULTS

### Best Case Scenario âœ“
- All abstract claims replicate with N = 141
- EMA shows strong convergent validity (r > 0.70)
- Temporal covariation is significant for key traits (NA, Det)
- EMA adds modest predictive value (Î”RÂ² > 0.01)

### Likely Scenario âœ“
- Most abstract claims replicate (maybe with slightly wider CIs)
- EMA shows moderate-strong validity (r > 0.50)
- Temporal covariation is modest (some traits show coupling)
- EMA provides equivalent predictive value to baseline

### Worst Case Scenario âš 
- Some interactions don't replicate (wider CIs cross zero)
- EMA validity is weak for some domains (r < 0.50)
- No temporal covariation (traits too stable)
- Baseline outperforms EMA (higher RÂ²)

**If worst case occurs**:
- Focus on domains with strong effects
- Emphasize ecological validity of EMA over baseline
- Discuss stability of traits during exam period
- Frame as methodological contribution regardless of specific effects

---

## MANUSCRIPT UPDATES NEEDED

### Abstract
**Current** (INCORRECT):
> "In 111 university students..."

**Revised** (CORRECT):
> "In 141 female university students..."

**Justification to add**:
> "Female participants were selected to control for sex-related variation 
> in vocal pitch characteristics."

### Methods
**Add section**: "Sample Composition"
> "The sample consisted exclusively of female students (N = 141, M_age = XX, 
> SD = XX). This design choice was made to minimize variance due to 
> sex-related differences in fundamental frequency and formant structure, 
> which could obscure personality-related effects. While this enhances 
> internal validity and statistical power, it limits generalizability to 
> male populations."

**Add section**: "EMA Validation"
> "To establish construct validity of the brief 15-item EMA measure, we 
> computed correlations between domain-aggregated EMA scores and the 
> full 220-item PID-5 administered at baseline. Convergent correlations 
> ranged from r = .XX to r = .XX (see Supplementary Materials), 
> indicating that the brief EMA captured substantial variance in 
> maladaptive trait dimensions."

**Add section**: "Analytic Strategy - Model Comparison"
> "To assess whether intensive EMA assessment provided predictive value 
> beyond single-session baseline measurement, we compared moderation 
> models using EMA-aggregated traits versus baseline PID-5 full scales. 
> Models were compared using Bayesian RÂ² and Leave-One-Out Cross-Validation 
> (LOO-IC)."

### Results
**Add section**: "Supplementary Analyses"

1. **EMA Validation**
   > "EMA measures demonstrated [strong/moderate] convergent validity with 
   > full PID-5 domains (median r = .XX, range = .XX - .XX). All correlations 
   > exceeded r = .50, supporting the use of brief EMA for trait assessment."

2. **Temporal Covariation**
   > "Within-person analyses revealed [significant/modest] temporal coupling 
   > between EMA trait fluctuations and acoustic changes. Specifically, 
   > [list traits with sig within-person effects]. This pattern supports 
   > the hypothesis that personality pathology modulates stress-related 
   > vocal changes dynamically."

3. **Model Comparison**
   > "Models using EMA-aggregated traits [showed equivalent/superior/inferior] 
   > predictive accuracy compared to baseline PID-5 (Î”RÂ² = .XX, Î”LOO = .XX). 
   > This suggests that intensive longitudinal assessment [adds value to/
   > provides comparable information to] traditional single-session measurement."

### Discussion
**Add**: "Methodological Contributions"
> "This study demonstrates the feasibility of integrating passive acoustic 
> sensing with intensive EMA to capture context-dependent personality 
> expression. The brief 15-item EMA showed strong convergent validity with 
> comprehensive trait assessment, while providing temporal resolution to 
> detect dynamic trait-context coupling."

**Add**: "Limitations"
> "Several limitations warrant consideration. First, the sample consisted 
> exclusively of female university students, limiting generalizability to 
> male populations and community samples. Second, [discuss other limitations 
> based on results...]"

---

## TIMELINE ESTIMATE

### This Week
- [ ] Verify data files (30 min)
- [ ] Run core scripts 01-03 (4-6 hours computing)
- [ ] Check replication of main findings (1 hour)

### Next Week
- [ ] Run supplementary scripts 08-09 (3-5 hours computing)
- [ ] Review all results systematically (2-3 hours)
- [ ] Identify any unexpected findings (1 hour)

### Week After
- [ ] Run script 07 if time allows (2-3 hours computing)
- [ ] Compile results for manuscript (1 day)
- [ ] Draft Methods section (1 day)
- [ ] Draft Results section (2 days)

**Manuscript Deadline**: February 14, 2026
**Current Date**: December 21, 2024
**Time Available**: ~7 weeks

---

## CRITICAL QUESTIONS TO RESOLVE

Based on results, you may need to decide:

1. **If EMA validation is weak** (r < 0.50 for some domains):
   - Use baseline PID-5 for those domains?
   - Acknowledge as limitation and proceed?
   - Run sensitivity analyses with both?

2. **If temporal covariation is absent**:
   - Frame traits as stable during exam period?
   - Emphasize between-person moderation instead?
   - Discuss null result as informative?

3. **If baseline outperforms EMA**:
   - Acknowledge in Discussion?
   - Emphasize ecological validity of EMA anyway?
   - Focus on methodological innovation?

4. **If some effects don't replicate**:
   - Which domains to emphasize in manuscript?
   - Should abstract be updated?
   - Report as exploratory instead of confirmatory?

---

## FINAL CHECKLIST

Before submission, verify:

- [ ] Sample composition disclosed (female only) âœ“
- [ ] All abstract claims supported by analyses âœ“
- [ ] EMA validation reported (convergent correlations) âœ“
- [ ] Temporal covariation tested (within-person effects) âœ“
- [ ] Model comparison conducted (EMA vs baseline) âœ“
- [ ] Effect sizes match abstract (or updated) 
- [ ] All models converged (Rhat < 1.01)
- [ ] Figures publication-quality
- [ ] Supplementary materials prepared
- [ ] Limitations section comprehensive

---

## QUESTIONS?

If anything is unclear or you encounter errors:

1. Check README_ANALYSIS_PIPELINE.md for troubleshooting
2. Verify all data files are in correct locations
3. Ensure scripts run in order (dependencies)
4. Check console output for specific error messages

---

**Next Steps**: 
1. Review this document carefully
2. Verify data files exist
3. Start running scripts in order
4. We'll review results together once complete!

Good luck! ðŸš€
